Immunome, Inc. (IMNM)Healthcare | Biotechnology | Bothell, United States | NasdaqCM
24.63 USD
+1.37
(5.890%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 24.65 +0.02 (0.081%) ⇧ (April 17, 2026, 7:04 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:57 p.m. EDT
IMNM presents a mixed picture with a high overall risk and negative earnings, suggesting significant volatility and uncertainty. The recent price movements show some momentum, but the lack of consistent dividends and negative fundamentals make it a risky proposition. The options activity indicates that traders are speculative, but the overall forecast model suggests a modest upward trend with limited reliability. Investors should proceed with caution, considering the high risk and uncertain fundamentals. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.092372 |
| AutoTheta | 0.092701 |
| AutoARIMA | 0.092911 |
| MSTL | 0.098815 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 50% |
| H-stat | 3.93 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.188 |
| Excess Kurtosis | -0.64 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.608 |
| Revenue per Share | 0.079 |
| Market Cap | 2,786,470,656 |
| Forward P/E | -11.65 |
| Beta | 2.14 |
| Website | https://immunome.com |
As of April 11, 2026, 3:57 p.m. EDT: The options data indicates a mix of speculation and volatility. The ATM IV is relatively high, suggesting increased uncertainty or expectations of price movement. The significant strikes show a concentration of both calls and puts around the current price, indicating that traders are hedging or anticipating a move. The presence of high IV spikes and significant OI in out-of-the-money strikes suggests that there is a lot of speculation around potential price swings. However, the overall trend in options activity does not clearly indicate a strong bullish or bearish sentiment, and the high volatility could be a sign of uncertainty.
| Attribute | Value |
|---|---|
| 52 Week Change | 2.07875 |
| Address1 | 18,702 North Creek Parkway |
| Address2 | Suite 100 |
| All Time High | 63.78 |
| All Time Low | 2.09 |
| Ask | 27.35 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 1,040,130 |
| Average Daily Volume3 Month | 1,345,417 |
| Average Volume | 1,345,417 |
| Average Volume10Days | 1,040,130 |
| Beta | 2.14 |
| Bid | 17.78 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 5.607 |
| City | Bothell |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 24.63 |
| Current Ratio | 14.687 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 24.81 |
| Day Low | 23.53 |
| Debt To Equity | 0.608 |
| Display Name | Immunome |
| Earnings Timestamp | 1,772,571,600 |
| Earnings Timestamp End | 1,778,616,000 |
| Earnings Timestamp Start | 1,778,616,000 |
| Ebitda | -211,647,008 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -10.096 |
| Enterprise To Revenue | 307.858 |
| Enterprise Value | 2,136,843,648 |
| Eps Current Year | -2.37077 |
| Eps Forward | -2.11364 |
| Eps Trailing Twelve Months | -2.43 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 21.8722 |
| Fifty Day Average Change | 2.7577991 |
| Fifty Day Average Change Percent | 0.12608695 |
| Fifty Two Week Change Percent | 207.87498 |
| Fifty Two Week High | 27.65 |
| Fifty Two Week High Change | -3.0200005 |
| Fifty Two Week High Change Percent | -0.10922244 |
| Fifty Two Week Low | 7.15 |
| Fifty Two Week Low Change | 17.48 |
| Fifty Two Week Low Change Percent | 2.444755 |
| Fifty Two Week Range | 7.15 - 27.65 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,601,645,400,000 |
| Float Shares | 94,305,572 |
| Forward Eps | -2.11364 |
| Forward P E | -11.652883 |
| Free Cashflow | -133,619,624 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 177 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.0 |
| Gross Profits | -170,344,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07481 |
| Held Percent Institutions | 1.03116 |
| Implied Shares Outstanding | 113,133,199 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,020-10-02 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington. |
| Long Name | Immunome, Inc. |
| Market | us_market |
| Market Cap | 2,786,470,656 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_108518404 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -212,394,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,786,470,691 |
| Number Of Analyst Opinions | 13 |
| Open | 23.85 |
| Operating Cashflow | -190,919,008 |
| Operating Margins | -30.84757 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 425 939 7410 |
| Post Market Change | 0.020000458 |
| Post Market Change Percent | 0.08120365 |
| Post Market Price | 24.65 |
| Post Market Time | 1,776,467,074 |
| Previous Close | 23.26 |
| Price Eps Current Year | -10.3890295 |
| Price Hint | 2 |
| Price To Book | 4.3927236 |
| Price To Sales Trailing12 Months | 401.4509 |
| Profit Margins | 0.0 |
| Quick Ratio | 14.525 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.14286 |
| Region | US |
| Regular Market Change | 1.37 |
| Regular Market Change Percent | 5.88994 |
| Regular Market Day High | 24.81 |
| Regular Market Day Low | 23.53 |
| Regular Market Day Range | 23.53 - 24.81 |
| Regular Market Open | 23.85 |
| Regular Market Previous Close | 23.26 |
| Regular Market Price | 24.63 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 991,458 |
| Return On Assets | -0.28983 |
| Return On Equity | -0.52089 |
| Revenue Growth | -1.0 |
| Revenue Per Share | 0.079 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 113,133,199 |
| Shares Percent Shares Out | 0.1675 |
| Shares Short | 18,945,536 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 17,887,518 |
| Short Name | Immunome, Inc. |
| Short Percent Of Float | 0.1731 |
| Short Ratio | 12.26 |
| Source Interval | 15 |
| State | WA |
| Symbol | IMNM |
| Target High Price | 40.0 |
| Target Low Price | 30.0 |
| Target Mean Price | 35.53846 |
| Target Median Price | 36.0 |
| Total Cash | 653,481,984 |
| Total Cash Per Share | 5.776 |
| Total Debt | 3,855,000 |
| Total Revenue | 6,941,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.43 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.895325 |
| Two Hundred Day Average Change | 7.7346745 |
| Two Hundred Day Average Change Percent | 0.4577997 |
| Type Disp | Equity |
| Volume | 991,458 |
| Website | https://immunome.com |
| Zip | 98,011 |